AI English summary of an SEC filing — figures as filed
Kimberly-Clark KMBKimberly-Clark said net sales for Q1 2025 were $4.8 billion, down 6.0% from the prior year. The company attributed the decline to a currency translation impact of about 2.4% and a combined impact of about 2.0% from the PPE divestiture and the exit of its private label diaper business in the US. It said organic sales fell 1.6%.
Key points
AI summaryKimberly-Clark said net sales for Q1 2025 were $4.8 billion, down 6.0% from the prior year. The company attributed the decline to a currency translation impact of about 2.4% and a combined impact of about 2.0% from the PPE divestiture and the exit of its private label diaper business in the US. It said organic sales fell 1.6%.
The company said diluted EPS for Q1 2025 was $1.70 (versus $1.91 a year earlier). Excluding $0.23 in charges related to the 2024 Transformation Initiative, adjusted EPS was $1.93, down 4.0% from the prior year. Adjusted operating profit was $844 million.
Kimberly-Clark said cash provided by operations for Q1 2025 was $327 million, down from $438 million a year earlier. The company attributed the decline mainly to lower operating profit. It said capital spending was $204 million, and it returned $466 million to shareholders through dividends and share repurchases.
The company said it expects adjusted operating profit for fiscal 2025 to be flat to positive on a constant-currency basis versus the prior year. Its previous expectation was high single-digit growth on a constant-currency basis. Adjusted free cash flow is now expected to be about $2 billion, compared with a previous expectation of more than $2 billion.
Summary
AI-writtenAnalysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.
Net sales of $4.8 billion in Q1, down 6.0%
Kimberly-Clark said net sales for Q1 2025 were $4.8 billion, down 6.0% from the prior year. The company attributed the decline to a currency translation impact of about 2.4% and a combined impact of about 2.0% from the PPE divestiture and the exit of its private label diaper business in the US. It said organic sales fell 1.6%.
Source · Based on the filing body and exhibits
Adjusted EPS $1.93, Diluted EPS $1.70
The company said diluted EPS for Q1 2025 was $1.70 (versus $1.91 a year earlier). Excluding $0.23 in charges related to the 2024 Transformation Initiative, adjusted EPS was $1.93, down 4.0% from the prior year. Adjusted operating profit was $844 million.
Source · Based on the filing body and exhibits
Q1 Operating Cash Flow and Shareholder Returns
Kimberly-Clark said cash provided by operations for Q1 2025 was $327 million, down from $438 million a year earlier. The company attributed the decline mainly to lower operating profit. It said capital spending was $204 million, and it returned $466 million to shareholders through dividends and share repurchases.
Source · Based on the filing body and exhibits
2025 Full-Year Outlook Revised
The company said it expects adjusted operating profit for fiscal 2025 to be flat to positive on a constant-currency basis versus the prior year. Its previous expectation was high single-digit growth on a constant-currency basis. Adjusted free cash flow is now expected to be about $2 billion, compared with a previous expectation of more than $2 billion.
Source · Based on the filing body and exhibits
AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.
Original filing
The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.
Loading the filing text…